Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
132 studies found for:    Open Studies | "Autonomic Nervous System Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Treatment of Post-SCI Hypotension
Conditions: Spinal Cord Injury;   Autonomic Dysreflexia;   Orthostatic Hypotension;   Baroreceptor Integrity;   Sympathetic Integrity;   Vagal Integrity;   Hypotension;   Cerebral Blood Flow;   Blood Pressure;   Venous Occlusion Plethysmography
Intervention: Drug: Midodrine Hydrochloride
22 Recruiting Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Conditions: Autonomic Failure;   Pure Autonomic Failure;   Multiple System Atrophy;   Parkinson Disease;   Orthostatic Hypotension
Interventions: Drug: Droxidopa;   Drug: Midodrine;   Drug: Placebo
23 Recruiting A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope
Condition: Syncope, Vasovagal
Interventions: Drug: Atomoxetine;   Drug: Matching Placebo
24 Recruiting Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Conditions: Chronic Fatigue Syndrome;   Myalgic Encephalomyelitis;   Systemic Exertion Intolerance Disease (SEID);   Postural Tachycardia Syndrome (POTS);   Neurally Mediated Syncope (NMS)
Interventions: Drug: Normal Saline;   Dietary Supplement: Oral Rehydration Solution
25 Recruiting Norepinephrine Transporter Blockade, Autonomic Failure
Condition: Multiple System Atrophy (MSA)
Interventions: Drug: Atomexetine;   Drug: Placebo
26 Recruiting Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
Condition: Neurogenic Orthostatic Hypotension
Interventions: Drug: Atomoxetine;   Drug: Placebo
27 Recruiting PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Conditions: Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
28 Not yet recruiting Unique Brainstem Biomarkers of Early Parkinson's Disease
Conditions: Parkinson's Disease;   Alzheimer's Disease;   Progressive Supranuclear Palsy;   Essential Tremor;   Multiple System Atrophy;   Drug Induced Parkinson's Disease;   Diffuse Lewy Body Disease;   Myasthenia Gravis
Interventions: Other: Electrical Brainstem Responses;   Other: Olfactory Tests;   Other: Visual Deprivation
29 Recruiting Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
Conditions: Multiple System Atrophy;   Orthostatic Hypotension;   Supine Hypertension
Interventions: Drug: Trimethaphan;   Drug: Placebo
30 Recruiting TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
Condition: Neurogenic Orthostatic Hypotension
Interventions: Drug: TD-9855;   Drug: Placebo
31 Recruiting POTS Adrenergic Ab (CIHR Aims #1&2)
Condition: Postural Tachycardia Syndrome
Interventions: Drug: Phenylephrine;   Drug: Isoproterenol
32 Recruiting Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   REM Sleep Behavior Disorder;   Pure Autonomic Failure;   Dementia With Lewy Bodies
33 Recruiting Observation of ImageReady™ MR Conditional Pacing System in China
Conditions: Arhythmia;   Atrioventricular Heart-block;   Chronic Bundle Branch or Branch Block;   Carotid Sinus Hypersensitivity Reaction Syndrome;   Vasovagal Syncope
Intervention: Device: ImageReady™ MR Conditional Pacing System
34 Not yet recruiting Dawn Simulation and Postural Hypotension
Condition: Orthostatic Hypotension
Intervention: Device: Light
35 Recruiting Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Interventions: Drug: Droxidopa capsules;   Drug: Placebo capsules
36 Recruiting Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
Conditions: Postural Tachycardia Syndrome (POTS);   Vasovagal Syncope (VVS);   Fainting
Interventions: Drug: Northera (Droxidopa);   Drug: Placebo
37 Recruiting Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
Condition: Vasovagal Syncope
Interventions: Drug: Atomoxetine;   Drug: Placebo
38 Recruiting Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty Patients
Condition: Osteoarthrosis
Interventions: Drug: Methylprednisolone;   Drug: Isotonic Sodium Chloride
39 Recruiting Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Vascular Parkinsonism
Intervention: Other: MRI exam of the brain
40 Recruiting Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
Conditions: Orthostatic Hypotension;   Pure Autonomic Failure;   Multiple System Atrophy;   Autonomic Failure
Interventions: Other: Abdominal compression;   Other: Sham abdominal compression;   Drug: Placebo pill;   Drug: midodrine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years